Edition:
United States

People: Alexandria Real Estate Equities Inc (ARE)

ARE on New York Consolidated

120.20USD
24 Feb 2017
Change (% chg)

$1.33 (+1.12%)
Prev Close
$118.87
Open
$118.87
Day's High
$120.51
Day's Low
$118.50
Volume
587,158
Avg. Vol
588,457
52-wk High
$120.51
52-wk Low
$75.24

Marcus, Joel 

Mr. Joel S. Marcus J.D., CPA., is Chairman of the Board, President, Chief Executive Officer of Alexandria Real Estate Equities, Inc. Joel S. Marcus is the Chairman, Chief Executive Officer (“CEO”), President, and Founder of Alexandria Real Estate Equities, Inc. (NYSE:ARE), the largest and leading REIT uniquely focused on collaborative science campuses in urban innovation clusters. Mr. Marcus co-founded Alexandria in 1994 as a garage startup with a business plan and $19 million of seed capital, and has led its growth into a publicly traded, investment-grade REIT with a total market capitalization of approximately $10.9 billion as of December 31, 2015, and dominant market presence in leading AAA locations, including Greater Boston, San Francisco, New York City, Seattle, San Diego, Maryland, and Research Triangle Park. Mr. Marcus also founded the renowned Alexandria Summit, an invitation-only gathering of the world’s foremost visionaries from the biopharmaceutical, medical, academic, financial, philanthropic, advocacy, and government communities, to address the most critical global healthcare challenges. Prior to co-founding Alexandria, Mr. Marcus had an extensive law career specializing in corporate finance and capital markets, venture capital, and mergers and acquisitions, with a unique expertise in the biopharmaceutical industry. He was also formerly a practicing certified public accountant and tax manager with Arthur Young & Co. focusing on the financing and taxation of REITs. Mr. Marcus serves on the boards of Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a clinical-stage biopharmaceutical company which completed its initial public offering in October 2014, Foundation for the National Institutes of Health (“FNIH”), and Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). He also served as a director of Rexford Industrial Realty, Inc. (NYSE:REXR) from 2013 to January 2015. Mr. Marcus received the Ernst & Young Entrepreneur of the Year Award (Los Angeles – Real Estate). He completed his undergraduate and Juris Doctor degre

Basic Compensation

Total Annual Compensation, USD 895,000
Restricted Stock Awards, USD 8,046,240
Long-Term Incentive Plans, USD --
All Other, USD 2,282,840
Fiscal Year Total, USD 11,224,100

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joel Marcus

11,224,100

Dean Shigenaga

4,686,480

Stephen Richardson

4,099,570

Thomas Andrews

4,605,420

Daniel Ryan

2,596,050

Peter Moglia

3,704,550
As Of  30 Dec 2015